OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Rahul Banerjee: Best Myeloma Study I've Ever Put Patients On

Michael Fradley: Warsaw to Host the International Cardio-Oncology Society GCOS Meeting in 2028

Fabrice Barlesi: A Collective Mobilization to Advance Research Against Childhood Cancer

Erika Hamilton: 10 New FDA-Approved Therapies for Breast Cancer Patients in 5 Months

How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation for Cancer Research

Oncology News, Insights, Stories by OncoDaily

Subcutaneous Pembrolizumab
OncoIndustry

Japan Approves Subcutaneous Pembrolizumab Across All Approved Indications

The Big Questions in Cancer Immunotherapy: Can We Treat Toxicity Without Losing Antitumor Immunity?
Immune Oncology

The Big Questions in Cancer Immunotherapy: Can We Treat Toxicity Without Losing Antitumor Immunity?

GU Oncology
Genitourinary Oncology

10 Must-Read Posts In GU Oncology This Week

Florian Lordick: How Should We Choose First-Line Treatment When CLDN18.2 and PD-L1 Coexist?

HER2CLIMB-05 Strengthens First-Line Maintenance in HER2-Positive Metastatic Breast Cancer With Tucatinib

γδ T Cells Reveal an MHC-Independent Immune Vulnerability in Small Cell Lung Cancer

Noha Rashad at COGC 2026: Precision Medicine in the Best and Worst of Times - Hope, but Not for All

Fabrice Barlesi: A Collective Mobilization to Advance Research Against Childhood Cancer

Erika Hamilton: 10 New FDA-Approved Therapies for Breast Cancer Patients in 5 Months

Julie Gralow: Global Health Catalyst Meeting in Boston

Voices

FDA Approvals

OncoDaily 100

Celebrities and Cancer

OncoCalendar

Immune-oncology

Gastrointestinal-Oncology

Breast-Oncology

Lung-Oncology

OncoDaily TV

Not To Miss

OncoGrants

Oncologist near me

Cancer types
CancerWorld

Oncologists

Oncology Drugs

OncoDaily Magazine

New Paper Alert

OncoDaily Medical Journal